Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Apr 2023
Historique:
received: 20 03 2023
revised: 02 04 2023
accepted: 14 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

The aim of this study was to determine the excretion of methylone and its metabolites in sweat following the ingestion of increasing controlled doses of 50, 100, 150 and 200 mg of methylone to twelve healthy volunteers involved in a clinical trial. Methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone (MDC) were analyzed in sweat patches by liquid chromatography-tandem mass spectrometry. Methylone and MDC were detected in sweat at 2 h and reached their highest accumulation (C

Identifiants

pubmed: 37108557
pii: ijms24087395
doi: 10.3390/ijms24087395
pmc: PMC10138602
pii:
doi:

Substances chimiques

Methamphetamine 44RAL3456C
methylone L4I4B1R01F

Types de publication

Clinical Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Department of antidrug Policies
ID : no number

Références

Biology (Basel). 2021 Aug 17;10(8):
pubmed: 34440023
J Anal Toxicol. 2016 Jan-Feb;40(1):12-6
pubmed: 26410364
Clin Chem. 2006 Aug;52(8):1539-45
pubmed: 16740647
Neuropsychopharmacology. 2016 Oct;41(11):2704-13
pubmed: 27206266
Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):5033-5042
pubmed: 35916799
J Anal Toxicol. 1997 Nov-Dec;21(7):570-5
pubmed: 9399128
Front Pharmacol. 2023 Feb 17;14:1122861
pubmed: 36873994
J Anal Toxicol. 2003 Jul-Aug;27(5):294-303
pubmed: 12908943
Eur J Pharmacol. 2007 Mar 22;559(2-3):132-7
pubmed: 17223101
Int J Mol Sci. 2022 Nov 23;23(23):
pubmed: 36498963
J Forensic Sci. 1996 Sep;41(5):851-4
pubmed: 8789845
Forensic Sci Int. 2001 Feb 15;116(2-3):89-106
pubmed: 11182260
J Anal Toxicol. 2012 Jul;36(6):444-51
pubmed: 22589523
Int J Legal Med. 2016 Mar;130(2):381-5
pubmed: 26071183
J Chromatogr A. 2014 Dec 29;1374:93-101
pubmed: 25482853
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):268-274
pubmed: 29364498
J Chromatogr B Biomed Sci Appl. 1998 Aug 21;713(1):111-35
pubmed: 9700555
J Chromatogr B Biomed Sci Appl. 1999 Oct 15;733(1-2):247-64
pubmed: 10572984
Eur J Pharmacol. 1999 Sep 17;381(1):63-9
pubmed: 10528135
Behav Pharmacol. 2015 Jun;26(4):345-52
pubmed: 25794333
J Anal Toxicol. 2004 May-Jun;28(4):253-9
pubmed: 15189676
Clin Chem. 2009 Mar;55(3):454-62
pubmed: 19168553
NIDA Res Monogr. 1997;167:108-29
pubmed: 9243559
Arch Int Pharmacodyn Ther. 1972 Oct;199(2):311-7
pubmed: 5070646
Clin Pharmacol Ther. 2019 Sep;106(3):596-604
pubmed: 30815856

Auteurs

Alessandro Di Giorgi (A)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.

Giorgia Sprega (G)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.

Lourdes Poyatos (L)

Department of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.
Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Cerdanyola del Vallés, Spain.

Esther Papaseit (E)

Department of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.
Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Cerdanyola del Vallés, Spain.

Clara Pérez-Mañá (C)

Department of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.
Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Cerdanyola del Vallés, Spain.

Annagiulia Di Trana (A)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy.

Maria Rosaria Varì (MR)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy.

Francesco Paolo Busardò (FP)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.

Simona Pichini (S)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy.

Simona Zaami (S)

Department of Anatomical, Histological, Forensic, and Orthopedic Sciences, Università La Sapienza, 00161 Rome, Italy.

Alfredo Fabrizio Lo Faro (AF)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.

Magí Farré (M)

Department of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.
Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Cerdanyola del Vallés, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH